No Data
Jinhe Biotechnology (002688.SZ): Signed a "Global Strategy Cooperation Agreement" with the School of Life Science and Technology at Shanghai Jiao Tong University.
On December 18, Gelonghui reported that Jinhe Biotechnology (002688.SZ) announced that on December 17, 2024, the company signed a "Global Strategy Cooperation Agreement" with the School of Life Science and Technology at Shanghai Jiao Tong University. The two parties intend to establish comprehensive strategic cooperation in the fields of Technology innovation and talent cultivation. The strategic cooperation between the company and the School of Life Science and Technology at Shanghai Jiao Tong University mainly addresses key core technological issues in enterprise production and seeks to find greater development space in the future. Both parties will carry out comprehensive cooperation, deploy a group of strategic, forward-looking, and innovative research projects, focusing on cutting-edge methods of synthetic biology in traditional fermentation research, micro...
Jinhe Biotechnology Includes Sheep, Lambs in Registration of Animal Diarrhea Medication
Jinhe Biotech: Report for the third quarter of 2024
jinhe biotechnology (002688.SZ): net income of 0.114 billion yuan in the first three quarters, a year-on-year increase of 10.38%.
Gelonghui October 27th | Jinhe Biotechnology (002688.SZ) announced that in the first three quarters of 2024, it achieved revenue of 1.657 billion yuan, a year-on-year increase of 5.57%; net income attributable to shareholders of the listed company was 0.114 billion yuan, a year-on-year increase of 10.38%, with basic earnings per share of 0.1461 yuan.
Jinhe Biotechnology (002688.SZ) released its performance for the first three quarters, with a net income of 0.114 billion yuan, a year-on-year increase of 10.38%.
jinhe biotechnology (002688.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue...
jinhe biotechnology (002688.SZ): Repurchase completed, cumulative expenditure of 50.0988 million yuan to repurchase 15.2215 million shares.
GeLongHui October 11th | Jinhe Biotechnology (002688.SZ) announced that as of October 10, 2024, the company has cumulatively repurchased 15.2215 million shares, accounting for 1.97% of the company's total share capital. The highest fill price was 5.16 yuan/share, and the lowest fill price was 2.92 yuan/share, with a total transaction amount of 50.0988 million yuan (excluding transaction costs). This buyback plan has been completed.
Some Jinhe Biotechnology CO., LTD. (SZSE:002688) Shareholders Look For Exit As Shares Take 27% Pounding
